A new medication therapy management model being rolled out by CMS will test strategies to improve medication use among Medicare beneficiaries enrolled in the Part D drug program.
A new medication therapy management (MTM) model being rolled out by CMS will test strategies to improve medication use among Medicare beneficiaries enrolled in the Part D drug program.
The Part D Enhanced MTM model will assess whether providing some Medicare prescription drugs plans with additional incentives and flexibilities granted to plan design will achieve better overall goals for MTM programs.
“Through this model, we are hopeful that Part D plans will invest in medication therapy management and identify new, effective strategies to optimize medication use and improve care coordination in Medicare,” Patrick Conway, MD, MSc, CMS acting principal deputy administrator and chief medical officer, said in a statement.
Some of the goals the program is looking to achieve include: improving compliance with medication protocols, including high-cost drugs; reducing medication-related problems; increasing patients’ knowledge of their medications to better achieve goals of therapy; and improving communication among prescribers, pharmacists, caregivers, and patients.
Testing for the model will begin January 1, 2017, with a 5-year performance period and will be tested in 11 states: Arizona, Florida, Iowa, Louisiana, Minnesota, Montana, Nebraska, North Dakota, South Dakota, Virginia, and Wyoming.
During the performance period, CMS will waive current MTM program requirements for participating plans in the test regions.
Supplemental Dental, Vision Benefits May Not Justify MA Payments for VA-Covered Veterans
May 22nd 2025Veterans primarily receiving care through the Department of Veterans Affairs (VA) similarly used dental and vision services under Medicare Advantage (MA) and traditional Medicare, challenging the justification for full MA capitated payments based on supplemental benefits.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen